A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The primary objective of this study is to determine pilot safety and efficacy data for a topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erimos Pharmaceuticals
• Collaborators: Planned Parenthood Delaware (Wilmington, DE); University of Maryland, Baltimore County
• Treatments: Masoprocol

Criteria

Inclusion Criteria:

• 18 years of age or older

• Negative pregnancy test

• Biopsy confirmed CIN 1, 2, or 3

Exclusion Criteria:

• Pregnancy or breast feeding